Alendronate sodium

This pharmaceutical-grade Alendronate Sodium (CAS 121268-17-5, trihydrate polymorph) is manufactured directly by Polpharma to USP and EP standards, drawing on the company's extensive commercial manufacturing experience and in-house production across its bisphosphonate family, which also includes risedronate, zoledronate, and ibandronate. It is used to treat osteoporosis linked to menopause, steroid use, or gonadal failure in patients at high fracture risk, as well as Paget's disease of bone, and is supplied without nitrosamine contamination risk to markets across North and South America, Europe, Australasia, Asia, the Middle East, and Africa.